BliNK Biomedical's Series A - II Round

BliNK Biomedical raised a round of funding on July 12, 2016. Investors include IDInvest Partners.

BliNK Biomedical is focused on the discovery and development of novel therapeutic antibodies with significant commercial potential in oncology and immuno-oncology. The Company has a suite of technolog…

Articles about BliNK Biomedical's Series A - II Round: